Accutin, a new disintegrin, inhibits angiogenesis in vitro and in vivo by acting as integrin α(v)β3 antagonist and inducing apoptosis

Blood

Volumn 92, Issue 9, 1998, Pages 3268-3276

  Yeh, Chia Hsin ^a   Peng, Hui Chin ^a   Huang, Tur Fu ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACCUTIN; ANGIOGENESIS INHIBITOR; DISINTEGRIN; INTEGRIN; SNAKE VENOM; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; HUMAN; HUMAN CELL; METASTASIS; METASTASIS INHIBITION; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; VASCULAR ENDOTHELIUM;

EID: 0001562465     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.9.3268     Document Type: Article

References (44)

1. Folkman J: Clinical applications of research on angiogenesis. N Engl J Med 333:1757, 1995
2. Bischoff J: Approaches to studying cell adhesion molecules in angiogenesis. Trends Cell Biol 5:69, 1995
3. Folkman J, Shing Y: Angiogenesis. J Cell Biol 267:10931, 1992
4. Bischoff J: Cell adhesion and angiogenesis. J Clin Invest 99:373, 1997
5. Hynes RO: Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69:11, 1992
6. Brooks PC, Clark RAF, Cheresh DA: Requirement of vascular integrin αvβ3 for angiogenesis. Science 264:569, 1994
7. Hammes HP, Brownlee M, Jonczyk A, Sutter A, Preissner KT: Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovacularization. Nat Med 2:529, 1996
8. Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, Cheresh DA: Definition of two angiogenic pathways by distinct αv integrins. Science 270:1500, 1995
9. Brooks PC, Montgomery AMP, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA: Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79:1157, 1994
10. Stromblad S, Cheresh DA: Integrins, angiogenesis and vascular cell survival. Chem Biol 3:881, 1996
11. Gould RJ, Polokoff MA, Friedman PA, Huang TF, Holt JC, Cook JT, Niewiarowski S: Disintegrins: A family of integrin inhibitory proteins from viper venoms. Proc Soc Exp Biol Med 195:168, 1990
12. Chang MC, Wang BR, Huang TF: Characterization of endothelial cell differential attachment to fibrin and fibrinogen and its inhibition by Arg-Gly-Asp containing peptides. Thromb Haemost 74:764, 1995
13. Juliano D, Wang Y, Marcinkiewicz C, Rosenthal LA, Stewart GJ, Niewiarowski S: Disintegrin interaction with αvβ3 integrin on human umbilical vein endothelial cells: Expression of ligand-induced binding site on β3 subunit. Exp Cell Res 255:132, 1996
14. Sheu JR, Yen MH, Kan YC, Huang WC, Chang PT, Luk HN: Inhibition of angiogenesis in vitro and in vivo: Comparison of the relative activities of triflavin, an Arg-Gly-Asp-containing peptide and anti-αvβ3 integrin monoclonal antibody. Biochim Biophys Acta 1336: 445, 1997
15. Huang TF, Li JY: The inhibitory effect of disintegrin, crotroxin, on angiogensis. Presentd at the XVIth Congress of the International Society on Thrombosis and Hasmostasis, Florence, Italy, 1997, PS-576, Thromb Haemost (suppl), p 141
16. Coller BS: A new murin monoclonal antibody reports on activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex. J Clin Invest 76:101, 1985
17. Scarborough RM, Naughton MA, Teng W, Rose JW, Philips DR, Nannizzi L, Arfsten A, Campbell AM, Charo IF: Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa. J Biol Chem 268:1066, 1993
18. Jaffe EA, Nachamn RL, Becker CG, Minnick CR: Culture of human endothelial cells derived from umbilical veins. J Clin Invest 52:2745, 1973
19. Kubota Y, Kleiman HK, Martin GR, Lawlwy TJ: Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary like structures. J Cell Biol 107:1589, 1988
20. Liu CZ, Wang YW, Shen MC, Huang TF: Analysis of huamn platelet glycoprotein IIb/IIIa by fluorescein isothiocyanate-conjugated disintegrins with flow cytometry. Thromb Haemost 72:919, 1994
21. Bissonnette RP, Echeverri F, Mahboubi A, Green DR: Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359:552, 1992
22. Stromblad S, Cheresh DA: Cell adhesion and angiogenesis. Trends Cell Biol 6:462, 1996
23. Grant DS, Tashiro KI, Bartolome SR, YamadaY, Martin GR, Kleinman HK: Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro. Cell 58:933, 1989
24. Wyllie AH: Glucocorticoid-induced thymocytes apoptosis is associated with endogenous endonuclease activation. Nature 284:555, 1980
25. Luscinskas FW, Lawler J: Integrins as dynamic regulators of vascular function. FASEB J 8:929, 1994
26. 3 integrins in hemostasis and vascular biology. Thromb Haemost 74:149, 1995
27. Coller BS: Platelet GPIIb/IIIa antagonists: The first anti-integrin receptor therapeutics. J Clin Invest 99:1467, 1997
28. Ruoslahti E, Reed JC: Anchorage dependence, integrins, and apoptosis. Cell 77:477, 1994
29. Varner JA, Cheresh DA: Integrins and cancer. Curr Opin Cell Biol 8:724, 1996
30. WAF1/CIP1 expression by vascular cell integrin αvβ3 during angiogenesis. J Clin Invest 98:426, 1996
31. Montgomery AMP, Reisfeld RA, Cheresh DA: Integrin αtvβ3 rescues melanoma from apoptosis in a three-dimensional dermal collagen. Proc Natl Acad Sci USA91:8856, 1994
32. Boudreau N, Sympson CJ, Werb Z, Bissei M: Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267:891, 1995
33. Meredith JE, Fazeli B, Schwartz MA: The extracellular matrix as a cell survival factor. Mol Biol Cell 4:953, 1993
34. Re F, Zanetti A, Sironi M, Polentarutti N, Lanfrancone L, Dejana Z, Colotta F: Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells. J Cell Biol 127:537, 1994
35. Varner JA, Nakada M, Jordan R, Coller BS: Anti-angiogenic properties of 7E3, an integrin β3 subunit antagonist, in the SCID mouse-human skin model of human angiogenesis. PD-645. Presented at the XVIth Congress of the International Society on Thrombosis and Hasmostasis, Florence, Italy, 1997, Thromb Haemost (suppl), p 158
36. Fidler IJ: Critical factor in the biology of human cancer metastasis: Twenty-eight G. H. A. Crowes Memorial Award Lecture. Cancer Res 50:6130, 1990
37. Weinstat-Saslow D, Steeg PS: Angiogenesis and colonization in the tumor metastatic process: Basic and applied advances. FASEB J 8:401, 1994
38. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J: Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastasis by a Lewis lung carcinoma. Cell 79:315, 1994
39. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J: Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277, 1997
40. Zetter BR: Angiogenesis and tumor metastasis. Annu Rev Med 49:407, 1998
41. Huang TF, Liu CZ: The biological activities of disintegrins and their possible applications. J Toxicol Toxin Rev 16:135, 1997
42. Sheu JR, Lin CH, Peng HC, Teng CM, Huang TF: Triflavin, an Arg-Gly-Asp containing peptide, inhibits tumor cell-induced platelet aggregation. Jpn J Cancer Res 84:1062, 1993
43. Chiang HS, Swaim MW, Huang TF: Characterization of platelet aggregation induced by human colon adenocarinoma cells and its inhibition by snake venom peptides, trigramin and rhodostomin. Br J Haematol 87:325, 1994
44. Folkman J: What is the evidence that tumors are angiogenesis-dependent? J Natl Cancer Invest 82:4, 1990